| ￥3500 | |
| Z04140-100 | |
|
|
|
|
|
|
|
|
|
| Species | Cynomolgus/Rhesus macaque | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 56.69 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 90-110 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized CD117, His, Cynomolgus/Rhesus macaque, His Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-CD117 Antibody, hFc Tag with the EC50 of 5.1ng/ml determined by ELISA. »
The purity of CD117, His, Cynomolgus/Rhesus macaque is greater than 95% as determined by SEC-HPLC. »
CD117, His, Cynomolgus/Rhesus macaque on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | The c-kit proto-oncogen (CD117) has been shown to be present in several cell types including normal and neoplastic hemopoietic cells. Among normal BM cells, CD117 expression has been found in about half of the CD34 precursors including progenitors committed to the erythroid, granulo-monocytic, and megakaryocytic cell lineages. |
| Synonyms | SCFR; PBT; CD117; ckit; c-kit; KIT |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
